CRMD
Closed
Cormedix Inc
11.79
-0.53 (-4.30%)
Last Update: 01 Jul 2025 23:19:00
Yesterday: 12.32
Day's Range: 11.72 - 12.265
Send
sign up or login to leave a comment!
When Written:
4.14
CorMedix Inc. is a pharmaceutical company that develops and commercializes therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The company's lead product is Neutrolin, a catheter lock solution for the prevention of catheter-related bloodstream infections and maintenance of catheter patency in hemodialysis patients. CorMedix is also developing DefenCath, an antimicrobial and antifungal catheter lock solution for the prevention of catheter-related bloodstream infections in patients with central venous catheters. The company is headquartered in Berkeley Heights, New Jersey, and was founded in 2006. CorMedix is listed on the NYSE American stock exchange under the ticker symbol CRMD.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








